The mortality rate for liver malignant neoplasms in Canadian women is projected to increase gradually from 2024 to 2028, with a rate rising from 6.7 to 7.2 deaths per 100,000 women. Comparing this with 2023, any increase signifies a growing concern. Year-on-year, there is a steady increase in this rate, reflecting an upward trend. The Compound Annual Growth Rate (CAGR) over this five-year window points to a consistent average rise annually.
Future trends to watch for:
- Potential advances in medical treatment and early detection methods that could alter these projections.
- Environmental and lifestyle factors influencing liver cancer rates in Canadian women.
- Government health initiatives aimed at lowering cancer-related mortality rates.
